Abstract: The invention encompasses methods and test strips for detecting the presence of cerebrospinal fluid (CSF) in a biological sample with a lateral flow device which uses lectin conjugates, anti-antigen conjugates, an immobilized serum line, and an immobilized anti-antigen line.
Type:
Grant
Filed:
June 8, 2022
Date of Patent:
February 20, 2024
Assignees:
NSPC Technologies, LLC, Gwangju Institute of Science and Technology